Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1595888 NEW YORK, NY
Back to AGIO Full portfolio

Position in AGIO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,280,311
-$4,901,357 QoQ
Shares Held
492,598
-28.1% QoQ
Ownership
0.825%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#36
of 238 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Derivatives in AGIO

reported options exposure · as of Jun 30, 2026
CallValue
$1,451,001
CallShares
39,100
PutValue
$7,974,939
PutShares
214,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. AGIO ranks #15 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in AGIO

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,974,939 214,900
2026-06-30 $18,280,311 492,598
2026-06-30 $1,451,001 39,100
2026-03-31 $1,661,053 49,100
2026-03-31 $3,623,193 107,100
2026-03-31 $23,181,668 685,240
2025-12-31 $4,807,052 176,600
2025-12-31 $30,514,980 1,121,050
2025-12-31 $4,123,830 151,500
2025-09-30 $2,328,120 58,000
2025-09-30 $15,860,116 395,120
2025-09-30 $401,400 10,000
2025-06-30 $1,113,843 33,489
2025-03-31 $3,694,846 126,104
2024-12-31 $7,032,926 214,027
2024-09-30 $368,769 8,300
2024-09-30 $5,620,616 126,505
2024-06-30 $7,624,262 176,815
2024-03-31 $3,641,402 124,535
2023-12-31 $2,182,926 98,021
2023-09-30 $1,361,868 55,025
2023-06-30 $1,971,637 69,620
2023-03-31 $587,365 25,571
2022-12-31 $834,424 29,716
2022-06-30 $1,119,119 50,479
2022-03-31 $222,341 7,638
2022-03-31 $692,818 23,800
2022-03-31 $640,420 22,000
2021-12-31 $3,967,409 120,700
2021-12-31 $2,764,367 84,100
2021-12-31 $2,238,414 68,099
2021-09-30 $4,107,350 89,000
2021-09-30 $5,053,425 109,500
2021-09-30 $3,098,741 67,145
2021-06-30 $7,439,850 135,000
2021-06-30 $5,285,049 95,900
2021-06-30 $1,707,031 30,975
2021-03-31 $3,093,906 59,913
2021-03-31 $3,676,768 71,200
2021-03-31 $3,599,308 69,700
2020-12-31 $2,000,416 46,167
2020-12-31 $6,300,182 145,400
2020-12-31 $4,657,975 107,500
2020-09-30 $2,168,460 61,956
2020-09-30 $2,359,000 67,400
2020-09-30 $1,599,500 45,700
2020-06-30 $620,368 11,600
2020-06-30 $599,884 11,217
2020-06-30 $7,128,884 133,300
2020-03-31 $326,416 9,200